French updated recommendations in Stage I to III melanoma treatment and management

B. Guillot, S. Dalac, M. G. Denis, A. Dupuy, J. F. Emile, A. De La Fouchardiere, E. Hindie, T. Jouary, N. Lassau, X. Mirabel, S. Piperno Neumann, S. De Raucourt, R. Vanwijck

    Résultats de recherche: Contribution à un journalArticleRevue par des pairs

    24 Citations (Scopus)

    Résumé

    As knowledge continues to develop, regular updates are necessary concerning recommendations for practice. The recommendations for the management of melanoma stages I to III were drawn up in 2005. At the request of the Société Française de Dermatologie, they have now been updated using the methodology for recommendations proposed by the Haute Autorité de Santé in France. In practice, the principal recommendations are as follows: for staging, it is recommended that the 7th edition of AJCC be used. The maximum excision margins have been reduced to 2 cm. Regarding adjuvant therapy, the place of interferon has been reduced and no validated emerging medication has yet been identified. Radiotherapy may be considered for patients in Stage III at high risk of relapse. The sentinel lymph node technique remains an option. Initial examination includes routine ultrasound as of Stage II, with other examinations being optional in stages IIC and III. A shorter strict follow-up period (3 years) is recommended for patients, but with greater emphasis on imaging.

    langue originaleAnglais
    Pages (de - à)594-602
    Nombre de pages9
    journalJournal of the European Academy of Dermatology and Venereology
    Volume31
    Numéro de publication4
    Les DOIs
    étatPublié - 1 avr. 2017

    Contient cette citation